UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3385) 3385
Magazine Article (28) 28
Web Resource (7) 7
Book Chapter (6) 6
Conference Proceeding (3) 3
Publication (2) 2
Book / eBook (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3095) 3095
hematinics - therapeutic use (2505) 2505
science & technology (2168) 2168
life sciences & biomedicine (2149) 2149
female (1501) 1501
male (1378) 1378
anemia - drug therapy (1318) 1318
erythropoietin - therapeutic use (1149) 1149
anemia (1090) 1090
middle aged (1018) 1018
aged (887) 887
anemia - etiology (831) 831
recombinant proteins (777) 777
adult (690) 690
epoetin alfa (654) 654
treatment outcome (639) 639
hematinics - administration & dosage (634) 634
urology & nephrology (595) 595
hematinics - adverse effects (537) 537
hematinics (488) 488
erythropoietin (473) 473
darbepoetin alfa (452) 452
erythropoietin - analogs & derivatives (445) 445
vitamin b 12 - therapeutic use (429) 429
hemoglobins - metabolism (426) 426
kidney failure, chronic - complications (379) 379
oncology (373) 373
anemia - blood (364) 364
renal dialysis (363) 363
old medline (362) 362
hemoglobins - analysis (342) 342
hemoglobin (338) 338
risk factors (332) 332
aged, 80 and over (328) 328
kidney failure, chronic - therapy (314) 314
erythropoietin - administration & dosage (310) 310
pharmacology & pharmacy (310) 310
quality of life (302) 302
care and treatment (294) 294
retrospective studies (291) 291
general & internal medicine (285) 285
corrinoids (283) 283
anemia, iron-deficiency - drug therapy (274) 274
anemia - therapy (264) 264
prospective studies (264) 264
folic acid - therapeutic use (263) 263
time factors (258) 258
abridged index medicus (254) 254
medicine, general & internal (254) 254
chronic kidney disease (251) 251
blood transfusion (249) 249
anemia - chemically induced (246) 246
erythropoietin - adverse effects (246) 246
neoplasms - drug therapy (245) 245
iron (237) 237
neoplasms - complications (236) 236
antineoplastic agents - adverse effects (233) 233
hematology (232) 232
animals (223) 223
iron - therapeutic use (223) 223
hematinics - pharmacology (222) 222
renal insufficiency, chronic - complications (221) 221
cancer (214) 214
hemodialysis (211) 211
adolescent (210) 210
nephrology (202) 202
dose-response relationship, drug (200) 200
health aspects (191) 191
medicine & public health (189) 189
practice guidelines as topic (186) 186
anemia - complications (184) 184
drug therapy (181) 181
research (181) 181
drug administration schedule (177) 177
anaemia (174) 174
united states (174) 174
analysis (168) 168
chronic disease (168) 168
erythropoiesis - drug effects (167) 167
nursing (167) 167
chronic kidney failure (164) 164
ferric compounds - therapeutic use (163) 163
hematinics - economics (163) 163
renal dialysis - adverse effects (163) 163
ferritins - blood (159) 159
randomized controlled trials as topic (157) 157
kidney failure, chronic - blood (156) 156
biomarkers - blood (152) 152
young adult (147) 147
anemia - diagnosis (145) 145
kidney diseases (145) 145
transplantation (145) 145
chemotherapy (140) 140
anemia, pernicious - therapy (137) 137
erythropoiesis-stimulating agents (135) 135
child (131) 131
mortality (131) 131
recombinant proteins - therapeutic use (131) 131
follow-up studies (130) 130
anemia, iron-deficiency - etiology (129) 129
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3132) 3132
French (74) 74
Spanish (74) 74
German (69) 69
Italian (39) 39
Russian (27) 27
Japanese (16) 16
Croatian (15) 15
Portuguese (14) 14
Hungarian (13) 13
Polish (8) 8
Dutch (5) 5
Czech (4) 4
Danish (3) 3
Romanian (3) 3
Swedish (3) 3
Chinese (2) 2
Bulgarian (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Postgraduate medical journal, ISSN 0032-5473, 12/2016, Volume 92, Issue 1094, pp. 726 - 734
An estimated 5.1 million Americans have chronic heart failure and this is expected to increase 25% by 2030. Heart failure is a clinical syndrome that evolves... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Vasodilator Agents - therapeutic use | Erythropoietin - therapeutic use | United States | Humans | Calcium Channel Blockers - therapeutic use | Heart Failure - physiopathology | Aminobutyrates - therapeutic use | Cardiotonic Agents - therapeutic use | Societies, Medical | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Isosorbide Dinitrate - therapeutic use | Cardiology | Platelet Aggregation Inhibitors - therapeutic use | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Hematinics - therapeutic use | Fumarates - therapeutic use | Anticoagulants - therapeutic use | Amides - therapeutic use | Antihypertensive Agents - therapeutic use | Evidence-Based Medicine | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | American Heart Association | Stroke Volume | Cardiovascular Agents - therapeutic use | Hydralazine - therapeutic use | Atrial Natriuretic Factor - therapeutic use | Iron - therapeutic use | Benzazepines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Diuretics - therapeutic use | Tetrazoles - therapeutic use | Peptide Fragments - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Practice Guidelines as Topic | Heart failure | Care and treatment | Usage | Analysis | Americans | Diagnosis | Cardiac output | Health aspects | Evidence-based medicine | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 05/2017, Volume 35, Issue 14, pp. 1591 - 1597
Journal Article
Clinical journal of the American Society of Nephrology, ISSN 1555-905X, 05/2010, Volume 5, Issue 5, pp. 905 - 911
Background and objectives: Vitamin D deficiency is highly prevalent in chronic kidney disease. The aim of this study was to evaluate the effects of oral... 
Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prospective Studies | Vitamin D Deficiency - complications | Erythropoietin - therapeutic use | Humans | Middle Aged | Vitamin D Deficiency - drug therapy | Ergocalciferols - therapeutic use | Male | Polyamines - therapeutic use | Parathyroid Hormone - blood | Bone Remodeling - drug effects | Calcium - blood | Erythropoietin - analogs & derivatives | C-Reactive Protein - metabolism | Cholecalciferol - administration & dosage | Time Factors | Vitamin D Deficiency - blood | Female | Kidney Diseases - blood | Kidney Diseases - complications | Sevelamer | Chelating Agents - therapeutic use | Natriuretic Peptide, Brain - blood | Hematinics - therapeutic use | Hypertrophy, Left Ventricular - blood | Administration, Oral | Hypertrophy, Left Ventricular - etiology | Hypertrophy, Left Ventricular - prevention & control | Inflammation Mediators - blood | Bone Density Conservation Agents - therapeutic use | Kidney Diseases - drug therapy | Treatment Outcome | Biomarkers - blood | Calcitriol - blood | Vitamin D - blood | Phosphorus - blood | Kidney Diseases - therapy | Vitamin D - analogs & derivatives | Aged | Darbepoetin alfa | Chronic Disease | Dietary Supplements | Vitamins - administration & dosage | Renal Dialysis | Serum Albumin - metabolism | Index Medicus | Original
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2013, Volume 368, Issue 13, pp. 1210 - 1219
..., and use of renin–angiotensin system blockers. 6 , 7 Small studies have suggested that increasing the hemoglobin level with the use of an erythropoiesis-stimulating... 
MORTALITY | CONTROLLED-TRIAL | CITY CARDIOMYOPATHY QUESTIONNAIRE | EPOETIN | MORBIDITY | REDUCTION | DOUBLE-BLIND | CHRONIC KIDNEY-DISEASE | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Shock, Septic - etiology | Double-Blind Method | Heart Failure, Systolic - drug therapy | Hematinics - therapeutic use | Erythropoietin - therapeutic use | Heart Failure, Systolic - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Erythropoietin - adverse effects | Hematinics - adverse effects | Male | Thromboembolism - etiology | Erythropoietin - analogs & derivatives | Stroke - etiology | Anemia - drug therapy | Treatment Failure | Female | Aged | Darbepoetin alfa | Anemia - etiology | Hemoglobins - analysis | Heart Failure, Systolic - complications | Heart failure | Usage | Care and treatment | Anemia | Patient outcomes | Diagnosis | Clinical trials | Patient safety | Hemoglobin | Thromboembolism | Patients | Heart diseases | Cancer | Index Medicus | Abridged Index Medicus | Shock | Systolic/mortality | Hematinics/adverse effects | chronic heart failure | Erythropoietin/analogs & derivatives | Thromboembolism/etiology | Klinisk medicin | Heart Failure | Anemia/drug therapy | Hematinics/therapeutic use | Erythropoietin/therapeutic use | Hemoglobins/analysis | Anemia/etiology | Erythropoietin/adverse effects | Stroke/etiology | Clinical Medicine | Systolic/complications | Septic/etiology | Systolic/drug therapy
Journal Article
British journal of haematology, ISSN 0007-1048, 05/2008, Volume 141, Issue 3, pp. 287 - 297
Journal Article
Journal Article
Journal Article